SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001654954-24-007151
Filing Date
2024-05-31
Accepted
2024-05-31 17:01:09
Documents
8
Effectiveness Date
2024-05-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 edsa_s8.htm S-8 60516
2 OPINION OF FASKEN MARTINEAU DUMOULIN LLP edsa_ex51.htm EX-5.1 6916
3 CONSENT edsa_ex232.htm EX-23.2 2830
4 FILING FEE TABLE edsa_ex107.htm EX-FILING FEES 13537
5 edsa_ex51img3.jpg GRAPHIC 11333
6 edsa_ex51img4.jpg GRAPHIC 769
7 edsa_ex232img5.jpg GRAPHIC 3723
8 edsa_ex232img6.jpg GRAPHIC 3177
  Complete submission text file 0001654954-24-007151.txt   111585
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-279887 | Film No.: 241010677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)